CA - Appili Therapeutics GAAP EPS of -$0.03 misses by $0.01
- Appili Therapeutics press release ( OTCQX:APLIF ): Q1 GAAP EPS of -$0.03 misses by $0.01 .
- As of June 30, 2022, the Company had cash and short-term investments of $5.55 million, compared to $6.66 million on March 31, 2022.
For further details see:
Appili Therapeutics GAAP EPS of -$0.03 misses by $0.01